With 33m in cash, the company has been hoarding cash to improve it's overall financial position and improve properties. Any sign of improving prop. Valuations will close the Nta gap.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%